<unk>  is a photosensitizing agent that is FDA approved for the treatment of patients with predominantly classic subfoveal choroidal neovascularization due to age-related macular degeneration, pathologic myopia or presumed ocular histoplasmosis.   Common adverse reactions include injection site reaction, blurred vision, photopsia, reduced visual acuity, visual field defect.
Verteporfin
Idraparinux
Cevimeline
Tecovirimat
Bexarotene
Porfimer
Peruvoside
Vicriviroc